CCL17 and lung cancer: Investigation of the relationship between CCL17 expression levels and survival outcomes in lung cancer patients using the Kaplan-Meier mapper database demonstrated that high CCL17 expression was significantly associated with favorable prognosis (OS, HR=0.79 (0.70-0.89), p=0.00012) (Figure 5D).